EUVIMEDEUVIMED entdecken
Open Access

Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer

Ashley M Henneghan, Kathleen M Van Dyk, Darren Haywood, Mansi Patel, Oscar Y Franco-Rocha, Soyeong Bang, Tamsin Longley, Rebecca Tasker, Tara Kaufmann, Emily W Paolillo, Raeanne C Moore, Nicolas H Hart

Breast Cancer Research and Treatment · 2025-01 · 209 (1) · 125-138

DOI: 10.1007/s10549-024-07479-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, online erschienen am 13.09.2024. Verfasst von Ashley M Henneghan und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, University of Texas at Austin, Austin, TX, USA. ahenneghan@nursing.utexas.edu. Hauptthemen laut MEDLINE: Quality of Life, Breast Neoplasms, Cognitive Dysfunction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Cancer Society, National Health and Medical Research Council, NINR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Little is known about cancer-related cognitive impairments (CRCI) in women with metastatic breast cancer (MBC). The purpose of this study is to (1) comprehensively describe CRCI and any associated psychosocial and behavioral symptoms, (2) determine observable sociodemographic and clinical risk factors for CRCI, and (3) explore cognitive and psychosocial predictors of quality of life and social functioning in women living with MBC. METHODS: Using a cross-sectional design, women with MBC completed assessments (objective and subjective measures of CRCI including 3 open-ended questions, measures of psychosocial and behavioral factors, and assessments of quality of life and social function), and data were analyzed using descriptive statistics, qualitative content analysis, correlation analyses, t tests, analysis of variance, and linear regression models. RESULTS: Data from 52 women were analyzed. 69.2% of the sample reported clinically significant CRCI and 46% of the sample scored < 1 standard deviation below the standardized mean on one or more cognitive tests. Those with triple-negative MBC (compared to HER2+), recurrent MBC (compared to de novo), and no history of chemotherapy had worse subjective CRCI, and those without history of surgery and older age had worse objective CRCI. Subjective CRCI, but not objective CRCI, was significantly associated with quality of life and social functioning. CONCLUSION: Subjective and objective CRCI are likely a common problem for those with MBC. Subjective CRCI is associated with poorer quality of life and lower social functioning. Healthcare providers should acknowledge cognitive symptoms, continually assess cognitive function, and address associated unmet needs across the MBC trajectory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeBreast NeoplasmsCognitive DysfunctionHumansFemaleMiddle AgedAgedCross-Sectional StudiesAdultNeoplasm MetastasisRisk Factors

Stichwörter der Autor:innen

Cancer-related cognitive impairmentsClinically meaningful thresholdsMetastatic breast cancerQuality of lifeSocial function

Autor:innen und Institutionen

  • School of Nursing, University of Texas at Austin, Austin, TX, USA. ahenneghan@nursing.utexas.edu.
  • Dell Medical School, University of Texas at Austin, Austin, TX, USA. ahenneghan@nursing.utexas.edu.
  • Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.
  • Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA.
  • Faculty of Health, Human Performance Research Centre, INSIGHT Research Institute, , University of Technology Sydney (UTS), Sydney, NSW, Australia.
  • Department of Mental Health, St. Vincent's Hospital Melbourne, Fitzroy, VIC, Australia.

Förderung

  • American Cancer Society
  • National Health and Medical Research Council
  • NINR NIH HHS
  • NCI NIH HHS
  • National Institute of Nursing Research
  • National Cancer Institute

Zitieren

APA

Henneghan, A. M., Van Dyk, K. M., Haywood, D., Patel, M., Franco-Rocha, O. Y., Bang, S., Longley, T., Tasker, R., Kaufmann, T., Paolillo, E. W., Moore, R. C., & Hart, N. H. (2025). Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer. Breast Cancer Research and Treatment, 209(1), 125-138. https://doi.org/10.1007/s10549-024-07479-4

Vancouver

Henneghan AM, Van Dyk KM, Haywood D, Patel M, Franco-Rocha OY, Bang S, et al. Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer. Breast Cancer Research and Treatment. 2025;209(1):125-138. doi:10.1007/s10549-024-07479-4

BibTeX
@article{Henneghan2025,
  author = {Henneghan, Ashley M and Van Dyk, Kathleen M and Haywood, Darren and Patel, Mansi and Franco-Rocha, Oscar Y and Bang, Soyeong and Longley, Tamsin and Tasker, Rebecca and Kaufmann, Tara and Paolillo, Emily W and Moore, Raeanne C and Hart, Nicolas H},
  title = {Characterizing cancer-related cognitive impairments and impact on quality of life in women with metastatic breast cancer},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  volume = {209},
  number = {1},
  pages = {125--138},
  doi = {10.1007/s10549-024-07479-4}
}
Kostenlos starten →